Literature DB >> 14719172

Arterial thromboembolism in the pediatric population.

Victoria Price1, M Patricia Massicotte.   

Abstract

The most common cause of arterial thromboembolism in the pediatric population is secondary to arterial catheterization. Non-catheter-related arterial thromboembolism is rare. The frequency of this complication has paralleled the advances in pediatric tertiary care that has lead to increasing numbers of children surviving life-threatening primary illnesses. Previously, these events were very rare and children were managed according to adult protocols. It is now known that the pathophysiology of thrombosis in children differs from that of adults and indeed is different for that of various age groups within the pediatric population, therefore requiring a unique diagnostic and therapeutic approach. This review highlights the available published data to support an evidence-based approach to the complication of arterial thromboembolism in the pediatric population, and underscores the urgent need for further randomized controlled trials.

Entities:  

Mesh:

Year:  2003        PMID: 14719172     DOI: 10.1055/s-2004-815623

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  3 in total

Review 1.  [Anaesthesia for cardiac catheterization in children].

Authors:  C Velik-Salchner; J Margreiter; V Wenzel; P Mair
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

2.  Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease.

Authors:  Joe Bontadelli; Alexander Moeller; Markus Schmugge; Thomas Schraner; Oliver Kretschmar; Urs Bauersfeld; Vera Bernet-Buettiker; Manuela Albisetti
Journal:  Intensive Care Med       Date:  2007-06-07       Impact factor: 17.440

3.  Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.

Authors:  Maria L Avila; Prakeshkumar S Shah; Leonardo R Brandão
Journal:  Cochrane Database Syst Rev       Date:  2020-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.